p.140 抽出テキスト

先天性心疾患,心臓大血管の構造的疾患(structural heart disease) に対するカテーテル治療のガイドライン

Cardiovasc Imaging 2016; 17: 1054-1062. PMID: 27002141 674. Kleczyński P, Dziewierz A, Daniec M, et al. Impact of post-dilatation on the reduction of paravalvular leak and mortality after transcatheter aortic valve implantation. Kardiol Pol 2017; 75: 742-748. PMID: 28819953 675. Tichelbäcker T, Bergau L, Puls M, et al. Insights into permanent pacemaker implantation following TAVR in a real-world cohort. PLoS One 2018; 13: e0204503. PMID: 30332419 676. Kawaguchi T, Yamaji K, Ishizu K, et al. Effect of postdilatation following balloon expandable transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2020; 96: E630-E639. PMID: 31880388 677. Barbanti M, Leipsic J, Binder R, et al. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol 2014; 63: 976-981. PMID: 24211502 678. Yashima F, Yamamoto M, Watanabe Y, et al. Impact of underfilling and overfilling in balloon-expandable transcatheter aortic valve implantation assessed by multidetector computed tomography: Insights from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry. Int J Cardiol 2016; 222: 738-744. PMID: 27521550 679. Sathananthan J, Sellers S, Barlow A, et al. Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: An Ex Vivo Bench Study. JACC Cardiovasc Interv 2018; 11: 1696-1705. PMID: 30190060 680. Mathur M, McCabe JM, Aldea G, et al. Overexpansion of the 29 mm SAPIEN 3 transcatheter heart valve in patients with large aortic annuli (area > 683 mm<sup>2</sup> ): A case series. Catheter Cardiovasc Interv 2018; 91: 1149-1156. PMID: 28836337 681. Miyasaka M, Yoon SH, Sharma RP, et al. Clinical Outcomes of Transcatheter Aortic Valve Implantation in Patients With Extremely Large Annulus and SAPIEN 3 Dimensions Based on Post-Procedural Computed Tomography. Circ J 2019; 83: 672-680. PMID: 30700661 682. Sengupta A, Zaid S, Kamioka N, et al. Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. JACC Cardiovasc Interv 2020; 13: 210-216. PMID: 31883715 683. Rogers T, Greenspun BC, Weissman G, et al. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv 2020; 13: 726-735. PMID: 32192693 684. Barbanti M, Costa G, Picci A, et al. Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study. JACC Cardiovasc Interv 2020; 13: 2542-2555. PMID: 33069648 685. Ochiai T, Chakravarty T, Yoon SH, et al. Coronary Access After TAVR. JACC Cardiovasc Interv 2020; 13: 693-705. PMID: 32192689 686. Dvir D, Webb JG. Transcatheter aortic valve-in-valve implantation for patients with degenerative surgical bioprosthetic valves. Circ J 2015; 79: 695-703. PMID: 25797021 687. Dvir D, Webb JG, Bleiziffer S, et al. Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014; 312: 162-170. PMID: 25005653 688. Dvir D, Bourguignon T, Otto CM, et al. VIVID (Valve in Valve International Data) Investigators. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. Circulation 2018; 137: 388-399. PMID: 29358344 689. Pibarot P, Simonato M, Barbanti M, et al. Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in- Valve Procedures. JACC Cardiovasc Interv 2018; 11: 133-141. PMID: 29348008 690. Bleiziffer S, Simonato M, Webb JG, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. Eur Heart J 2020; 41: 2731-2742. PMID: 32592401 691. Bapat V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention 2014; 10 Suppl U: U44-U51. PMID: 25256331 692. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J 2018; 39: 687-695. PMID: 29020413 693. Miller M, Snyder M, Horne BD, et al. Transcatheter Aortic Valvein-Valve Replacement for Degenerated Stentless Bioprosthetic Aortic Valves: Results of a Multicenter Retrospective Analysis. JACC Cardiovasc Interv 2019; 12: 1217-1226. PMID: 31272667 694. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv 2015; 8: e002079.  PMID: 25593122 695. Dvir D, Khan J, Kornowski R, et al. Novel strategies in aortic valvein-valve therapy including bioprosthetic valve fracture and BASILI- CA. EuroIntervention 2018; 14: AB74-AB82. PMID: 30158098 696. Isner JM, Samuels DA, Slovenkai GA, et al. Mechanism of aortic balloon valvuloplasty: fracture of valvular calcific deposits. Ann Intern Med 1988; 108: 377-380. PMID: 3341674 697. Moreno PR, Jang IK, Newell JB, et al. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 1994; 23: 1071-1075. PMID: 8144770 698. Feldman T. Transseptal antegrade access for aortic valvuloplasty. Catheter Cardiovasc Interv 2000; 50: 492-494. PMID: 10931628 699. Eisenhauer AC, Hadjipetrou P, Piemonte TC. Balloon aortic valvuloplasty revisited: the role of the inoue balloon and transseptal antegrade approach. Catheter Cardiovasc Interv 2000; 50: 484-491. PMID: 10931627 700. Aksoy O, Yousefzai R, Singh D, et al. Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart 2011; 97: 838-843. PMID: 20962337 701. Sakata Y, Syed Z, Salinger MH, et al. Percutaneous balloon aortic valvuloplasty: antegrade transseptal vs. conventional retrograde transarterial approach. Catheter Cardiovasc Interv 2005; 64: 314- 321. PMID: 15736255 702. Cheng TO. Multivalve percutaneous balloon valvuloplasty. Cathet Cardiovasc Diagn 1989; 16: 109-112. PMID: 2521573 703. Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988; 60: 299-308. PMID: 3190958 704. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661. PMID: 18820172 705. Krasuski RA, Assar MD, Wang A, et al. Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis. Am J Cardiol 2004; 93: 936-939. PMID: 15050505 706. Iung B, Cormier B, Elias J, et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994; 73: 398-400. PMID: 8109557 707. Reid CL, McKay CR, Chandraratna PA, et al. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 1987; 76: 628-636. PMID: 3621523 708. Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87: 394-402. PMID: 6700245 709. Hung JS. Atrial septal puncture technique in percutaneous transvenous mitral commissurotomy: mitral valvuloplasty using the Inoue balloon catheter technique. Cathet Cardiovasc Diagn 1992; 26: 275- 284. PMID: 1394414 710. Feldman T, Carroll JD, Herrmann HC, et al. Effect of balloon size and stepwise inflation technique on the acute results of Inoue mitral commissurotomy. Inoue Balloon Catheter Investigators. Cathet Cardiovasc Diagn 1993; 28: 199-205. PMID: 8439994 711. Iung B, Cormier B, Ducimetière P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation 1996; 94: 2124-2130. PMID: 8901662 712. Fatkin D, Roy P, Morgan JJ, et al. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 1993; 21: 390-397. PMID: 8426003 713. Feldman T. Hemodynamic results, clinical outcome, and complications of Inoue balloon mitral valvotomy. Cathet Cardiovasc Diagn 1994; Suppl: 2-7. PMID: 7994738 714. Ribeiro PA, al Zaibag M, Abdullah M. Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis. Am Heart J 1993; 125: 1110-1114. PMID: 8465735 715. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants. Multicenter experience with balloon mitral